Osaka, Japan

Terukazu Tanaka


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1984-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Terukazu Tanaka: Innovator in Pharmaceutical Composition

Introduction

Terukazu Tanaka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Tanaka has focused on enhancing the stability and effectiveness of pharmaceutical compositions.

Latest Patents

Tanaka's latest patents include a novel sugar-coated pharmaceutical composition that incorporates pullulan in the sugar layer. This innovation aims to prevent the brownish color change of the composition over time. Additionally, he has developed a sesquihydrate of a naphthyridine derivative, specifically a compound known as ATT-2266.sesquihydrate. This compound is prepared by heating a specific naphthyridine derivative in the presence of water, resulting in a more stable form that offers superior dissolution rates and transference into the body.

Career Highlights

Throughout his career, Tanaka has worked with prominent companies such as Dainippon Pharmaceutical Company, Limited and Laboratoire Roger Bellon. His work has significantly impacted the pharmaceutical industry, particularly in the development of stable and effective drug formulations.

Collaborations

Tanaka has collaborated with notable individuals in his field, including Hitoshi Ichihashi and Yu Imasato. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Terukazu Tanaka's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to improving drug stability and effectiveness, making a lasting impact on pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…